Quantitative Multiplex Immunofluorescence Evaluation Of The Tumor Microenvironment In Pretreatment Tumors Of Patients With Metastatic Breast Cancer And Serous Ovarian Carcinoma Treated With Liposomal Eribulin
CANCER INVESTIGATION(2021)
摘要
Eribulin inhibits microtubule polymerization and suppresses epithelial-mesenchymal transition. Conventional pathology approaches have not identified a precise predictive biomarker for Eribulin. We performed qmIF on pre-treatment tissue from 11 patients (6 TNBC, 5 HGSOC) treated with Eribulin-LF. T-lymphocytes were the dominant immune-subset in TME, with higher levels detected in stroma vs tumor (9% vs 2%). Greater density of CD3+ (p = 0.01) and CD3 + CD8+ (p = 0.03) cells and closer proximity between CD3 + CD8+ and tumor cells was observed in the patients with disease control (PR + SD) vs. progressive disease. QmIF identified an association between TIL infiltration and Eribulin-LF sensitivity, which should be evaluated further in prospective studies.
更多查看译文
关键词
Metastatic breast cancer, metastatic ovarian cancer, EMT, tumor microenvironment, Eribulin-LF, Eribulin, quantitative multiplex immunofluorescence, tumor immunobiology, phase I clinical trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要